DexCom, Inc. CEO Kevin Sayer told investors during his presentation at the 2022 J.P. Morgan Healthcare Conference that clinical data from the company’s G7 continuous glucose monitoring system had exceeded all expectations. “The performance of this product is something I really never thought I would see in nearly 30 years in this business,” Sayer said.
J.P. Morgan Highlights: Medtech Company Updates For 2022
CEOs Present At J.P. Morgan's Annual Healthcare Conference
The annual J.P. Morgan Healthcare Conference saw major medtech companies describe their experiences in 2021 and expectations for 2022 as they continue to cope with COVID-19.
